June 20, 2025

Platelet Indices Signal Aspirin Resistance in Preeclampsia

New research links changes in platelet count and volume to aspirin nonresponsiveness in pregnant women who develop preeclampsia, offering insights into potential biomarkers for risk monitoring.

Conexiant

June 20, 2025

Hormone Levels May Guard Against MetS

A large national study of U.S. women ages 12 to 49 found that higher levels of testosterone and sex hormone–binding globulin were linked to lower odds of metabolic syndrome, with differences observed across racial and ethnic groups.

Conexiant

June 16, 2025

Combination of Weight Gain, Age at Pregnancy Could Increase Breast Cancer Risk

The risk of developing breast cancer could be higher among women who experience notable weight gain and either give birth after age 30 or don’t have children, according to findings presented at the Eu...

The ASCO Post

June 16, 2025

Updated Guidance on Antirheumatic Drug Use

New 2024 EULAR recommendations offer evidence-based guidance for the use of antirheumatic drugs during pregnancy, lactation, and conception planning in patients with rheumatic and musculoskeletal diseases.

Conexiant

June 12, 2025

Smoking Cessation Drugs Show No Birth Risk

A large multinational cohort study found no increased risk of major congenital malformations associated with nicotine replacement therapy, varenicline, or bupropion use during early pregnancy.

Conexiant

June 05, 2025

Can Adolescent Diets Predict Fatherhood?

New research shows fathers who improved their diet as teenagers were more likely to promote healthy eating in their children and had kids who ate more fruits and vegetables.

Conexiant

June 04, 2025

Is ‘PCOS’ Due for a Rename?

A global survey reveals strong support for renaming PCOS, citing that the current term misrepresents the condition’s full range of reproductive, metabolic, and psychological features.

Conexiant

June 02, 2025

New COVID Vaccine Approved for High-Risk Groups

After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.

Conexiant

May 30, 2025

HPV Vaccine After Surgery Reduces Virus Persistence

Post-surgical HPV vaccination was linked to significantly lower rates of HPV positivity in women with cervical lesions, suggesting a potential role in viral clearance and reduced persistence after treatment.

Conexiant